We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Diurnal Triglyceridemia in Relation to Alcohol Intake

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01786421
Recruitment Status : Completed
First Posted : February 8, 2013
Last Update Posted : February 8, 2013
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to determine the impact of alcohol consumption in diurnal triglyceridemia in a free living situation.

Condition or disease
Healthy Subjects Hyperlipidemias Type 2 Diabetes Mellitus Cardiovascular Diseases

Study Design

Study Type : Observational
Actual Enrollment : 273 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational Study of Diurnal Triglyceridemia in Relation to Alcohol Intake
Primary Completion Date : December 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Alcohol
U.S. FDA Resources

Groups and Cohorts

General population
Healthy volunteers,patients with hyperlipidemia,a known medical history of cardiovascular diseases or type 2 diabetes mellitus.

Outcome Measures

Primary Outcome Measures :
  1. Determination of diurnal triglyceridemia depend on alcohol intake [ Time Frame: For 3 days. ]
    Capillary triglyceridemia was measured by a triglyceride testing device on six fixed time-points.

Secondary Outcome Measures :
  1. Gender differences in diurnal triglyceridemia by alcohol consumption [ Time Frame: For 3 days ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Subjects were healthy volunteers or patients with hyperlipidemia or a known medical history of cardiovascular diseases, type 2 diabetes mellitus participating in several clinical studies with the same protocol, aimed to investigate factors influencing postprandial lipemia

Inclusion Criteria:

  • Healthy volunteers

Patients with:

  • Hyperlipidemia
  • Type 2 Diabetes Mellitus
  • Cardiovascular diseases

Exclusion Criteria:

  • Renal disease
  • Liver disease
  • Thyroid disease
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01786421

Sint Franciscus Gasthuis
Rotterdam, Netherlands, 10900
Utrecht University Medical Center
Utrecht, Netherlands
Sponsors and Collaborators
Sint Franciscus Gasthuis
More Information

Responsible Party: Ana Torres do Rego, Medical Doctor, Sint Franciscus Gasthuis
ClinicalTrials.gov Identifier: NCT01786421     History of Changes
Other Study ID Numbers: AlcoholTG_SFG_2013
First Posted: February 8, 2013    Key Record Dates
Last Update Posted: February 8, 2013
Last Verified: February 2013

Keywords provided by Ana Torres do Rego, Sint Franciscus Gasthuis:

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Alcohol Drinking
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Lipid Metabolism Disorders
Drinking Behavior